Akebia Therapeutics
AKBA
AKBA
189 hedge funds and large institutions have $1.52B invested in Akebia Therapeutics in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 77 increasing their positions, 43 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% more funds holding
Funds holding: 155 → 189 (+34)
7.55% more ownership
Funds ownership: 71.45% → 79% (+7.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
189
Holding in Top 10
3
Calls
$26.1M
Puts
$3.02M
Top Buyers
| 1 | +$75.4M | |
| 2 | +$47.7M | |
| 3 | +$21.7M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$21.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.5M |
Top Sellers
| 1 | -$34.3M | |
| 2 | -$19.1M | |
| 3 | -$16.8M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$6.79M |
| 5 |
Millennium Management
New York
|
-$6.52M |